跳至主要内容
临床试验/NL-OMON21523
NL-OMON21523招募中不适用

Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery.

Department of Anesthesiology, Erasmus MC Rotterdam, the Netherlands0 个研究点目标入组 6,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
6,000

研究概览

简要总结

Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J. 2004 Dec;148(6):1047-52.

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who are (1) aged 40 years or older, (2) scheduled for elective noncardiac surgery and (3) have an estimated risk for cardiovascular death of more than 1%, will be enrolled in the DECREASE-IV trial.

排除标准

  • Exclusion criteria for this trial are: the use of beta-blockers; a contraindication for beta-blocker use; the use of statins prior to randomisation; a contraindication for statin use; unstable coronary heart disease, evidence of 3-vessel disease or left main disease; elevated cholesterol according to the national cholesterol consensus; emergency surgery; unability or unwillingness to provide written informed consent; and previous participation in this same trial.

研究者

发起方
Department of Anesthesiology, Erasmus MC Rotterdam, the Netherlands

相似试验